human umbilical cord derived mesenchymal stem cell therapy (UC-MSC) / Hunan GuangXiu-Gaoxin Life Sci - LARVOL DELTA

Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Cognitive Decline by Restoring Senescent Microglial Function via NF-κB-SREBP1 Pathway Inhibition. (PubMed, Aging Cell) - "Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have been extensively studied for their significant potential in anti-aging...This pathway modulation attenuates neuronal damage and promotes the apoptosis of senescent neurons, facilitating the clearance of damaged neurons. These findings highlight the therapeutic potential of hUC-MSCs in age-related neurodegenerative disorders."

Journal • CNS Disorders • Cognitive Disorders • Inflammation

Mesenchymal stem cell transplantation alleviated TBI-induced lung injury by inhibiting PAD4-dependent NET formation. (PubMed, J Adv Res) - "Our findings demonstrate that hUC-MSCs significantly alleviate TBI-induced lung injury by inhibiting neutrophil infiltration and NET formation, offering potential therapeutic benefits for treating TBI-associated lung complications. These results highlight the clinical potential of hUC-MSCs in addressing both neurological and pulmonary damage in TBI patients."

Journal • Acute Lung Injury • Acute Respiratory Distress Syndrome • CNS Disorders • Pulmonary Disease • Respiratory Diseases • Transplantation • Vascular Neurology